1型糖尿病中心血管健康指标有利聚集与心血管疾病发病风险:EURODIAB前瞻性并发症研究
EURODIAB前瞻性并发症研究纳入2313例1型糖尿病患者,平均随访7.2±1.3年,163例发生心血管疾病。研究发现HbA1c<57 mmol/mol(<7.4%)与收缩压<112 mmHg且舒张压<70 mmHg分别与心血管疾病风险降低37%和44%相关,且有利指标聚集呈剂量-反应关系。
要点
- HbA1c<57 mmol/mol(<7.4%)者心血管疾病风险显著低于HbA1c较高者(HR 0.63)。
- 收缩压<112 mmHg且舒张压<70 mmHg者心血管疾病风险显著低于血压较高组(HR 0.56)。
- 具有4项及以上有利指标者心血管疾病风险显著低于无有利指标者(HR 0.37)。
核心结论
- 低HbA1c和低血压是1型糖尿病患者保护性心血管健康指标,针对所有心血管健康指标可能比针对单一指标更有效预防心血管疾病。
研究设计与样本
- EURODIAB前瞻性并发症研究,纳入2313例1型糖尿病患者(51%为男性,平均±标准差年龄32±9岁),平均±标准差随访7.2±1.3年,采用Cox比例风险模型计算心血管疾病发病风险比(HR)及其95%置信区间(CI)。
主要发现
- 随访期间163例发生心血管疾病。
- HbA1c<57 mmol/mol(<7.4%)者较HbA1c较高者心血管疾病风险显著降低37%(HR 0.63,95%CI 0.44–0.91)。
- 收缩压<112 mmHg且舒张压<70 mmHg者较血压较高组心血管疾病风险显著降低44%(HR 0.56,95%CI 0.34–0.92)。
- 校正性别和糖尿病诊断年龄后,具有4项及以上有利指标者较无有利指标者心血管疾病风险显著降低(HR 0.37,95%CI 0.18–0.76)。
- 有利指标聚集程度越高,HR越低,呈剂量-反应关系。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this prospective study was to examine CVD risk reduction in type 1 diabetes (1) for people with favourable cardiovascular health metrics and (2) by clustering of these metrics. METHODS: Data from 2313 participants from the EURODIAB Prospective Complications Study were analysed. All had type 1 diabetes (51% men, mean ± SD age 32 ± 9 years). Seven cardiovascular health metrics were studied-smoking, BMI, physical activity, a diet score, total cholesterol/HDL-cholesterol ratio, combined systolic and diastolic BP and HbA1c-divided into favourable/less favourable categories. Cox proportional hazards models were used to calculate HRs (95% CIs) of incident CVD for each metric. Clusters were made by scoring each individual by the number of favourable metrics. RESULTS: A total of 163 people developed incident CVD during a mean ± SD follow-up of 7.2 ± 1.3 years. Participants with more favourable HbA1c levels of <57 mmol/mol (<7.4%) had a 37% significantly lower CVD risk than those with a less favourable HbA1c (HR [95% CI] 0.63 [0.44, 0.91]), and participants with a more favourable BP (systolic BP <112 mmHg and diastolic BP <70 mmHg) had a 44% significantly lower CVD risk than participants in the less favourable BP group (HR [95% CI] 0.56 [0.34, 0.92]). There was a dose-response relation with a lower HR observed with greater clustering of more favourable metrics: people with four or more favourable metrics had an HR of 0.37 (95% CI 0.18, 0.76), adjusted for sex and age at diabetes diagnosis, compared with those with no favourable metrics. CONCLUSIONS/INTERPRETATION: Low HbA1c and low BP were protective cardiovascular health metrics in our study of people with type 1 diabetes. Targeting all cardiovascular health metrics could be more effective in preventing CVD than targeting single metrics.
引用
- Soulimane S, Balkau B, Vogtschmidt YD, et al. Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia. 2022. PMID: 35411407. doi:10.1007/s00125-022-05698-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。